A Q&A On Comprehensive Genomic Profiling in rare cancers and cancer of unknown primary.
4 ভিউ
• 07/10/23
0
0
বসান
administrator
সাবস্ক্রাইবার
A Q&A with TargetCancer Foundation on Comprehensive Genomic Profiling and its relevance in rare cancers and cancer of unknown primary, as well as its incorporation in the TRACK Study.
Featuring:
Jim Palma, Executive Director, TargetCancer Foundation
Dr. Prasanth Reddy, VP of Medical Affairs, Foundation Medicine
আরো দেখুন
ফেসবুক মন্তব্য
SORT BY-
শীর্ষ মন্তব্য
-
সর্বশেষ মন্তব্য